Girentuximab (Anti-CA9 / Carbonic anhydrase 9)
Product Specifications
CAS Number
916138-87-9
Synonyms
G250; cG250
Target
Carbonic Anhydrase
Applications
Metabolism
Additionnal Information
Girentuximab (Anti-CA9 / Carbonic anhydrase 9) is a chimeric monoclonal antibody that targets and binds to Carbonic Anhydrase IX (CAIX) / Carbonic Anhydrase 9 (CA9), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC) . MW:145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
